الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 81 |  |  |
| | | from | 81 | | |
Abstract
Skin cancer represents 0.31 % of total ACOD patients.
Patients where categorized into two categories, non melanoma and cutaneous melanoma skin cancer.
In non melanoma, surgery was done for 54.2% of cases, and 71.2 % of cases received radiotherapy, where the most commonly prescribed dose was 50 Gy/25 fractions for the squamous cell carcinoma and 45 Gy/25 fractions.
In melanoma, chemotherapy was the main line of treatment for 61 % of cases; DTIC was used as monotherapy or in combination in 33.3% of cases.Radiotherapy was given as a palliative treatment in metastatic cases.
Lack of data acquisition and deficient records are the main problems that interfere with statistical analysis and study results.
In view of these observations, we may suggest the following recommendations:
1. A national cancer registration is mandatory.
2. We should recommend the initiation of a computerized automated filing system rather than the manual medical records to improve registration, data information system and documentation. ( Appendix I )
3. Investigational drugs, continued phase one evaluation of chemotherapeutic agents, biologic agents that target gene expression and immunologic agents is needed.
4. We should recommend a multidisciplinary management of skin cancers including the oncologist, surgical oncologist, dermatologist, pathologist, psychological support, nursing team as well